nofo RFA-MH-26-195

Funding for R01 clinical trials to improve adult ADHD treatment strategies

The National Institute of Mental Health plans to announce a funding opportunity for developing evidence-based treatments for adult ADHD that do not rely solely on stimulant medications. The treatments may involve nonstimulant medications, psychosocial interventions, or device-based methods, either alone or in combination, particularly when stimulant drugs are not effective, tolerable, or prefe…

The objective of this NOFO is to provide evidence for the optimal treatment of ADHD in adults, given its relatively recent acceptance as a formal diagnostic category. While stimulant drugs offer the advantages of rapid onset of action and history of efficacy, the risk of adverse effects, depende…

Funding Source

Agency: National Institutes of Health

Awards & funding

Total Funding: $3M

Eligibility

Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Small businesses
State governments

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizatio…

Supporting links

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.